Poirier Michael S. 4
4 · Qualigen Therapeutics, Inc. · Filed Apr 21, 2021
Insider Transaction Report
Form 4
Poirier Michael S.
DirectorChairman, President & CEO.
Transactions
- Purchase
Common Stock
2021-04-20$1.80/sh+11,005$19,809→ 11,005 total(indirect: By IRA)
Holdings
- 169,202
Common Stock